EUCTR2006-004710-41-AT进行中（未招募）不适用
Multizentrische Therapieoptimierungsstudie AML-BFM 2004 zur Behandlung der akuten myeloischen Leukämien bei Kindern und JugendlichenMulticentric therapy optimizing study AML-BFM 2004 for the treatment of acute myeloic leukaemias for children and juveniles - AML-BFM 2004
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 550
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- age 0-18 y
- •- de novo AML, including Down Syndrome, primary Myelosarkoma or Acute Mixed Lineage
- •- treatment in the participating centers in Austria
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- AML als secondary malignant tumour
- •- patients with primary syndroma (exception Down Syndrom)
- •- Pregnancy
- •- treatment for more than 14 days with different intense Induction Therapy
- •- conducting diseases than ban the intented therapy according protocoll AML-BFM 2004
研究者
相似试验
进行中（未招募）
不适用
Multicentre study to optimize therapy of B-ALL and high grade non-Hodgkin Lymphoma in Adults - NDBurkitt`s Lymphoma Burkitt`s LeukemiaMedDRA version: 9.1Level: SOCClassification code 10005329EUCTR2009-012950-19-ITILG (Northern Italy Leukemia Group)
进行中（未招募）
不适用
Multicentre study of optimization of therapy in mature B-cell acute lymphoblastic leukemia and Burkitt's lymphoma in adults (over 15 years) - BURKIMABEUCTR2005-001067-64-ESPETHEMA Foundation20
尚未招募
Unknown
Treatment of pediatric very high-risk acute lymphoblastic leukemia in KoreaNeoplasmsKCT0009352Seoul National University Hospital74
已完成
3 期
Established Status Epilepticus Treatment TrialBenzodiazepine Refractory Status EpilepticusNCT01960075University of Virginia478
招募中
Unknown
SWAN studyJPRN-jRCTs031230213Murata Toshinori70